Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.

Background: Canada recently enacted legislation to authorize the collection of data on laboratory incidents involving a biological agent. This is done by the Public Health Agency of Canada (PHAC) as part of a comprehensive national program that protects Canadians from the health and safety risks posed by human and terrestrial animal pathogens and toxins.

Objective: To describe the first year of data on laboratory exposure incidents and/or laboratory-acquired infections in Canada since the came into effect.

Epidemiology of Hypertension in Canada: An Update.

Background: High blood pressure (BP) is the leading cause of death and disability in the world. The objective of this analysis was to perform a detailed update of the epidemiology of hypertension in Canada.

Methods: Five population-based data sources were analyzed.

Methodology of the 2009 Survey on Living with Chronic Diseases in Canada--hypertension component.

Introduction: The Survey on Living with Chronic Diseases in Canada--hypertension component (SLCDC-H) is a 20-minute cross-sectional telephone survey on hypertension diagnosis and management. Sampled from the 2008 Canadian Community Health Survey (CCHS), the SLCDC-H includes Canadians (aged ≥ 20 years) with self-reported hypertension from the ten provinces.

Methods: The questionnaire was developed by Delphi technique, externally reviewed and qualitatively tested.

Report summary. Diabetes in Canada: facts and figures from a public health perspective.

"Diabetes in Canada: facts and figures from a public health perspective" is the first comprehensive diabetes surveillance report published by the Public Health Agency of Canada. The report aims to support public health professionals and organizations in developing effective, evidence-based public health policies and programs to prevent and manage diabetes and its complications. The report, developed in collaboration with provincial and territorial governments, the Canadian Diabetes Association, Juvenile Diabetes Research Foundation, CNIB, Health Canada and the academic community, uses data from national health surveys and vital statistics, as well as population-based administrative data from the Canadian Chronic Disease Surveillance System (CCDSS).

Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension.

Background: Some of the greatest barriers to achieving blood pressure control are perceived to be failure to prescribe antihypertensive medication and lack of adherence to medication prescriptions.

Methods: Self-reported data from 6017 Canadians with diagnosed hypertension who responded to the 2008 Canadian Community Health Survey and the 2009 Survey on Living with Chronic Diseases in Canada were examined.

Results: The majority (82%) of individuals with diagnosed hypertension reported using antihypertensive medications.